HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linglin Xie Selected Research

Morpholinos

10/2019Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linglin Xie Research Topics

Disease

8Non-alcoholic Fatty Liver Disease
01/2023 - 01/2019
6Neoplasms (Cancer)
09/2022 - 04/2010
6Obesity
01/2022 - 05/2013
5Inflammation (Inflammations)
01/2023 - 01/2021
5Weight Loss (Weight Reduction)
01/2022 - 09/2007
4Body Weight (Weight, Body)
01/2019 - 04/2010
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2019
3Glucose Intolerance
01/2021 - 12/2018
3Insulin Resistance
01/2021 - 02/2008
2Hyperplasia
08/2022 - 01/2019
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2022 - 04/2022
2Weight Gain
01/2021 - 01/2003
1Pregnancy Complications
05/2023
1Mitochondrial Diseases (Mitochondrial Disease)
01/2023
1Fibrosis (Cirrhosis)
01/2023
1Liver Neoplasms (Liver Cancer)
01/2023
1Breast Neoplasms (Breast Cancer)
01/2023
1Diarrhea
11/2022
1Colitis
11/2022
1Abdominal Pain (Pain, Abdominal)
11/2022
1Alcoholic Fatty Liver
01/2022
1Gestational Diabetes (Gestational Diabetes Mellitus)
11/2021
1Wounds and Injuries (Trauma)
01/2021
1Dyslipidemias (Dyslipidemia)
01/2021
1Sclerosing Cholangitis
10/2019
1Hypertriglyceridemia
01/2019
1Cholestasis
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Hyperglycemia
01/2019
1Malnutrition (Nutritional Deficiencies)
01/2017
1Bites and Stings (Sting)
01/2017
1Metabolic Diseases (Metabolic Disease)
01/2017
1Carcinogenesis
02/2013
1Atrial Heart Septal Defects (Atrial Septal Defect)
08/2012

Drug/Important Bio-Agent (IBA)

5Methionine (L-Methionine)FDA Link
01/2023 - 01/2003
3CarbonIBA
01/2023 - 01/2021
3Insulin (Novolin)FDA Link
01/2023 - 04/2010
3Hormones (Hormone)IBA
01/2019 - 02/2013
3Glucose (Dextrose)FDA LinkGeneric
12/2018 - 04/2010
3LeptinIBA
05/2013 - 02/2008
2CytokinesIBA
01/2023 - 04/2022
2Choline (Choline Chloride)IBA
01/2023 - 01/2022
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2023 - 04/2010
2LipidsIBA
01/2022 - 01/2019
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2021 - 01/2019
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2013 - 02/2013
2AdiponectinIBA
05/2013 - 02/2008
2AdipokinesIBA
05/2013 - 02/2008
1LigandsIBA
05/2023
1Fatty Acids (Saturated Fatty Acids)IBA
01/2023
1EnzymesIBA
01/2023
1nasIBA
01/2023
1Adenosine KinaseIBA
01/2023
1Culture MediaIBA
01/2023
1InterferonsIBA
01/2023
1Rosiglitazone (Avandia)FDA Link
01/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Calcitriol Receptors (Calcitriol Receptor)IBA
11/2022
1Dextran SulfateIBA
11/2022
1CadmiumIBA
08/2022
1fms-Like Tyrosine Kinase 3IBA
04/2022
1indoleIBA
01/2022
1Streptozocin (Streptozotocin)FDA Link
11/2021
1TriterpenesIBA
01/2021
1celastrolIBA
01/2021
1MorpholinosIBA
10/2019
1VimentinIBA
10/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019
1MelatoninIBA
01/2019
1Arylalkylamine N-AcetyltransferaseIBA
01/2019
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2017
1vadimezanIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1Interferon Type IIBA
01/2017
1Insulin-Like PeptidesIBA
05/2013
1GlucocorticoidsIBA
05/2013
1AMP-Activated Protein KinasesIBA
02/2013
1Insulin-Like Growth Factor I (IGF-1)IBA
02/2013
1TOR Serine-Threonine KinasesIBA
02/2013
1Transcription Factors (Transcription Factor)IBA
08/2012
1DNA (Deoxyribonucleic Acid)IBA
12/2011
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
04/2010
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
04/2010
1CarcinogensIBA
09/2007

Therapy/Procedure

1Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2022
1Therapeutics
09/2022
1Immunotherapy
06/2022
1Pinealectomy
01/2019
1Caloric Restriction
05/2013